Evidence map›Paper›PMID 21098350›Full record

ArticleArchives of internal medicine2010

Validation of an atrial fibrillation risk algorithm in whites and African Americans.

Renate B Schnabel, Thor Aspelund, Guo Li, Lisa M Sullivan, Astrid Suchy-Dicey, Tamara B Harris, Michael J Pencina, Ralph B D'Agostino, Daniel Levy, William B Kannel and 10 more

Registry-linked trialAbstract readValidation Study
In one paragraph

Article in Archives of internal medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04657900 (Predicting Patient-level New Onset Atrial Fibrillation From Population-based Nationwide Electronic Health Records), which is not on this map. Cited by 71 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 3 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04657900 completednot on this mapstarted 2020, after this paper: background citation

Predicting Patient-level New Onset Atrial Fibrillation From Population-based Nationwide Electronic Health Records: A Precision Medicine Investigation Using Artificial Intelligence

TypeobservationalSponsorUniversity of LeedsRan2020 to 2023Enrolled140,000ConditionsAtrial FibrillationArmsObservational
3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 3 syntheses or guidelines pooled it, 138 citations in OpenAlex.

  1. Prediction models for atrial fibrillation applicable in the community: a systematic review and meta-analysis.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2020
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Risk Factors Influencing Outcomes of Atrial Fibrillation in ALLHAT.Journal of the National Medical Association · 2018
    Trial
  6. Trial
  7. Trial
  8. Enhanced Atrial Fibrillation Prediction in ESUS Patients with Hypergraph-based Pre-training.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2026
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 3 countries.

Renate B SchnabelDepartment of Medicine, Johannes Gutenberg University, Mainz, Germany.
Thor Aspelund
Guo Li
Lisa M Sullivan
Astrid Suchy-Dicey
Tamara B Harris
Michael J Pencina
Ralph B D'Agostino
Daniel Levy
William B Kannel
Thomas J Wang
Richard A Kronmal
Philip A Wolf
Gregory L Burke
Lenore J Launer
Ramachandran S Vasan
Bruce M Psaty
Emelia J Benjamin
Vilmundur Gudnason
Susan R Heckbert
University of Washington · USNational Institutes of Health · USUniversity of Iceland · ISGroup Health Cooperative · USHarvard University Press · USJohannes Gutenberg University Mainz · DEWake Forest University · US

Funding

Framingham Project/LevyZIAHL006001 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LEVY, DANIEL · 2009 to 2025
$51.1M
PRECURSORS OF STROKE INCIDENCE AND PROGNOSISR01NS017950 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Hugo Javier Aparicio, Jose Rafael Romero · 1985 to 2026
$22.9M
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVALR01HL092577 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI BENJAMIN, EMELIA J., ELLINOR, PATRICK THOMAS · 2009 to 2025
$20.6M
CHS Events Follow-up StudyR01HL080295 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M · 2009 to 2014
$6.3M
WGA Study to Identify Genetic Variants Associated with CV Events in CHSR01HL087652 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M · 2007 to 2009
$5.1M
CHS Events Follow-up StudyU01HL080295 · NHLBI · UNIVERSITY OF WASHINGTON · PI PSATY, BRUCE M · 2005 to 2008
$4.6M
Atrial Fibrillation: Incidence, Risk Factors, and GeneticsR01HL068986 · NHLBI · UNIVERSITY OF WASHINGTON · PI HECKBERT, SUSAN R · 2002 to 2010
$3.5M
Genetic Markers of Brain AgingZIAAG007270 · NIA · NATIONAL INSTITUTE ON AGING · PI LAUNER, LENORE J · 2009 to 2025
$2.7M
Brain aging and cardiovascular risk factors and diseaseZIAAG007480 · NIA · NATIONAL INSTITUTE ON AGING · PI LAUNER, LENORE J · 2011 to 2025
$2.7M
Aging and Inflammation: Longitudinal Markers and Genetics in the Framingham StudyR01AG028321 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BENJAMIN, EMELIA J. · 2006 to 2010
$1.8M
Exceptional Aging Across the Life Span: Framingham StudyR01AG029451 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MURABITO, JOANNE M · 2008 to 2011
$1.3M
Risk prediction of atrial fibrillation: clinical, biological and genetic markersRC1HL101056 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ALONSO, ALVARO, BENJAMIN, EMELIA J. · 2009 to 2010
$967k
NHLBI NIH HHS 2K24 HL04334NHLBI NIH HHS HL092577NHLBI NIH HHS K24 HL004334NHLBI NIH HHS N01 HC015103NHLBI NIH HHS N01 HC025195NHLBI NIH HHS N01 HC035129NHLBI NIH HHS N01 HC055222NHLBI NIH HHS N01 HC085079NHLBI NIH HHS N01 HC085080NHLBI NIH HHS N01 HC085081NHLBI NIH HHS N01 HC085082NHLBI NIH HHS N01 HC085083NHLBI NIH HHS N01 HC085084NHLBI NIH HHS N01 HC085085NHLBI NIH HHS N01 HC085086NHLBI NIH HHS N01-HC-25195NHLBI NIH HHS N01 HC-55222NHLBI NIH HHS N01 HC-85079NHLBI NIH HHS N01 HC-85080NHLBI NIH HHS N01 HC-85081NHLBI NIH HHS N01 HC-85082NHLBI NIH HHS N01 HC-85083NHLBI NIH HHS N01 HC-85084NHLBI NIH HHS N01 HC-85085NHLBI NIH HHS N01 HC-85086NHLBI NIH HHS R01 HL068986NHLBI NIH HHS R01 HL080295NHLBI NIH HHS R01 HL087652NHLBI NIH HHS R01 HL092577NHLBI NIH HHS RC1 HL101056NHLBI NIH HHS U01 HL080295NIA NIH HHS AG028321NIA NIH HHS AG029451NIA NIH HHS N01 AG012100NIA NIH HHS R01 AG028321NIA NIH HHS R01 AG029451NIA NIH HHS R56 AG029451NINDS NIH HHS R01 NS017950NINDS NIH HHS R01 NS 17950
6 · The paper itself

Abstract

backgroundWe sought to validate a recently published risk algorithm for incident atrial fibrillation (AF) in independent cohorts and other racial groups.

methodsWe evaluated the performance of a Framingham Heart Study (FHS)-derived risk algorithm modified for 5-year incidence of AF in the FHS (n = 4764 participants) and 2 geographically and racially diverse cohorts in the age range 45 to 95 years: AGES (the Age, Gene/Environment Susceptibility-Reykjavik Study) (n = 4238) and CHS (the Cardiovascular Health Study) (n = 5410, of whom 874 [16.2%] were African Americans). The risk algorithm included age, sex, body mass index, systolic blood pressure, electrocardiographic PR interval, hypertension treatment, and heart failure.

resultsWe found 1359 incident AF events in 100 074 person-years of follow-up. Unadjusted 5-year event rates differed by cohort (AGES, 12.8 cases/1000 person-years; CHS whites, 22.7 cases/1000 person-years; and FHS, 4.5 cases/1000 person-years) and by race (CHS African Americans, 18.4 cases/1000 person-years). The strongest risk factors in all samples were age and heart failure. The relative risks for incident AF associated with risk factors were comparable across cohorts and race groups. After recalibration for baseline incidence and risk factor distribution, the Framingham algorithm, reported in C statistic, performed reasonably well in all samples: AGES, 0.67 (95% confidence interval [CI], 0.64-0.71); CHS whites, 0.68 (95% CI, 0.66-0.70); and CHS African Americans, 0.66 (95% CI, 0.61-0.71). Risk factors combined in the algorithm explained between 47.0% (AGES) and 63.6% (FHS) of the population-attributable risk.

conclusionsRisk of incident AF in community-dwelling whites and African Americans can be assessed reliably by routinely available and potentially modifiable clinical variables. Seven risk factors accounted for up to 64% of risk.

Indexed as

AlgorithmsBlack PeopleWhite PeopleAgedAged, 80 and overAge FactorsAtrial FibrillationBlack or African AmericanBlood PressureBody Mass IndexCohort StudiesElectrocardiographyEuropeFemaleFollow-Up StudiesHeart Failure

Identifiers

PMID21098350
PMCPMC3021784
OpenAlexW2141617447

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.